F.D.A. Delays Clinical Trial of Embryonic Stem Cells
Thursday, May 15, 2008 - 06:28
in Health & Medicine
The Geron Corporation announced Wednesday that its plans to begin the first clinical trial using embryonic stem cells had been delayed by federal regulators.
Read the whole article on NY Times Health
More from NY Times Health
Related
- UCI embryonic stem cell therapy restores walking ability in rats with neck injuriesMon, 9 Nov 2009, 13:31:25 EST
- Project Zero Delay accelerates drug's path to clinical trialMon, 3 Aug 2009, 16:24:58 EDT
- New layer of control over human embryonic stem cells foundThu, 30 Apr 2009, 13:16:30 EDT
- Protein is key to embryonic stem cell differentiationWed, 18 Mar 2009, 12:46:43 EDT
- Study finds blood cells can be reprogrammed to act as embryonic stem cellsMon, 20 Apr 2009, 14:28:41 EDT